Correlation Between Arcus Biosciences and Insmed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Insmed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Insmed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Insmed Inc, you can compare the effects of market volatilities on Arcus Biosciences and Insmed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Insmed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Insmed.

Diversification Opportunities for Arcus Biosciences and Insmed

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Arcus and Insmed is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Insmed Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Insmed Inc and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Insmed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Insmed Inc has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Insmed go up and down completely randomly.

Pair Corralation between Arcus Biosciences and Insmed

Given the investment horizon of 90 days Arcus Biosciences is expected to generate 4.25 times less return on investment than Insmed. In addition to that, Arcus Biosciences is 1.22 times more volatile than Insmed Inc. It trades about 0.0 of its total potential returns per unit of risk. Insmed Inc is currently generating about 0.01 per unit of volatility. If you would invest  7,096  in Insmed Inc on September 25, 2024 and sell it today you would lose (38.00) from holding Insmed Inc or give up 0.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Arcus Biosciences  vs.  Insmed Inc

 Performance 
       Timeline  
Arcus Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Arcus Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Arcus Biosciences is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Insmed Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Insmed Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Insmed is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Arcus Biosciences and Insmed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arcus Biosciences and Insmed

The main advantage of trading using opposite Arcus Biosciences and Insmed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Insmed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insmed will offset losses from the drop in Insmed's long position.
The idea behind Arcus Biosciences and Insmed Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world